Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 15 and up

Chlorzoxazone versus orphenadrine citrate for relieving bruxism-related jaw and facial pain

Official title: Clinical Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism- Related Orofacial Pain: A Randomized Clinical Trial

Run by University of Baghdad · NCT07109882 · Data updated 2026-11-12

This trial will test whether chlorzoxazone or orphenadrine citrate better reduces jaw and facial pain in people who grind their teeth (bruxism).

More Bruxism trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages15 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations1 site (Baghdad)
StatusRecruiting
StartedJuly 22, 2025
Main results expectedAugust 1, 2025
Study endsAugust 30, 2025
Registry record updatedAugust 7, 2025
Trial IDNCT07109882 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people older than 15 with bruxism-related orofacial/TMJ pain who have no chronic systemic illnesses and are not taking analgesics.

Probably not a fit

Patients with recent orofacial or head injuries, those with chronic systemic illness, or those who have taken analgesics in the prior 14 days are unlikely to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, interventional Phase 4 trial will enroll 60 patients older than 15 with orofacial and temporomandibular pain and no chronic systemic illness. Participants will be randomly assigned to receive either chlorzoxazone (Relaxon) or orphenadrine citrate (Norgesic) twice daily for two weeks. Pain will be measured using a visual analogue scale at baseline, day 7, and day 14, and temporomandibular joint function will be evaluated at baseline and day 14. Results will be analyzed using nonparametric statistics in SPSS v29 to compare short-term pain and TMJ parameter changes between groups.

Why it matters

Potential benefit: If successful, the results could identify which commonly available muscle relaxant provides better short-term relief of bruxism-related orofacial pain.

How similar studies have gone: Muscle relaxants have been used for orofacial muscle pain, but direct head-to-head comparisons for bruxism are limited, so this specific comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged above 15 years-old complaining of orofacial and temporomandibular disorder/pain.
* Patients with no history of chronic systemic illness.

Exclusion Criteria:

* Patients with orofacial injuries.
* Patients with head injuries.
* Patients Taking analgesics for the last 14 days.

Where it's running

  • College of Dentistry
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.